Testing effectiveness (Phase 2)Study completedNCT02718495
What this trial is testing
Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis
Who this might be right for
Cystic Fibrosis
Proteostasis Therapeutics, Inc. 56